This collaborative program involves investigators from Departments of Biomedical Engineering and Radiology at Washington University in St. Louis. The ultimate goal of this work is to develop and validate Au nanocages with targeting ligands as a novel class of therapeutic agents, which can serve as nanoscale transducers to effectively convert NIR light into heat and selectively kill cancer cells without any adverse side effects. The scope of this research includes: i) developing robust methods for large-scale production of Au nanocages with controlled size, wall thickness, absorption cross section, and surface functionality;ii) understanding the in vitro targeting capability and the role of Au nanocages in photothermal destruction of cancer cells;iii) assessing the biodistribution of PEGylated Au nanocages and maximizing their capability for passive targeting of tumor in an animal model;iv) developing Au nanocages with the right size and surface chemistry for a combination of passive and active tumor targeting in an animal model;and v) validating and optimizing the use of functionalized Au nanocages for photothermal destruction of tumor in an animal model. If successful, the technology to be developed in this application will provide a highly effective and selective method for cancer treatment. By varying the ratio of absorption to scattering cross section, the functionalized Au nanocages could also serve as molecular contrast agents for a number of imaging modalities, including optical coherence tomography (OCT), photoacoustic tomography (PAT), two-photon fluorescence, as well as CT (because Au is also a strong absorber of X-ray). As a result, Au nanocages have the potential to become a novel class of dual agents for both diagnostic and therapeutic applications

Public Health Relevance

The ultimate goal of this work is to develop and validate gold nanocages with targeting ligands as a novel class of therapeutic agents, which can serve as nanoscale transducers to effectively convert NIR light into heat and selectively kill cancer cells without any adverse side effects. If successful, the technology to be developed in this application will provide a highly effective and selective method for cancer treatment. By varying the ratio of absorption to scattering cross section, the gold nanocages could also serve as molecular contrast agents for a number of imaging modalities, including optical coherence tomography, photoacoustic tomography, two-photon fluorescence, as well as computed tomography (because gold is also a strong absorber of X-ray). To this end, gold nanocages have the potential to become a novel class of dual agents for both diagnostic and therapeutic applications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA138527-04
Application #
8450128
Study Section
Nanotechnology Study Section (NANO)
Program Officer
Wong, Rosemary S
Project Start
2010-02-19
Project End
2014-11-30
Budget Start
2012-12-01
Budget End
2013-11-30
Support Year
4
Fiscal Year
2013
Total Cost
$368,344
Indirect Cost
$80,424
Name
Georgia Institute of Technology
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
097394084
City
Atlanta
State
GA
Country
United States
Zip Code
30332
Moran, Christine H; Rycenga, Matthew; Xia, Xiaohu et al. (2014) Using well-defined Ag nanocubes as substrates to quantify the spatial resolution and penetration depth of surface-enhanced Raman scattering imaging. Nanotechnology 25:014007
Black, Kvar C L; Wang, Yucai; Luehmann, Hannah P et al. (2014) Radioactive 198Au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution. ACS Nano 8:4385-94
Sun, Tianmeng; Wang, Yi; Wang, Yucai et al. (2014) Using SV119-gold nanocage conjugates to eradicate cancer stem cells through a combination of photothermal and chemo therapies. Adv Healthc Mater 3:1283-91
Wang, Yucai; Shim, Min Suk; Levinson, Nathanael S et al. (2014) Stimuli-Responsive Materials for Controlled Release of Theranostic Agents. Adv Funct Mater 24:4206-4220
Hyun, Dong Choon; Lu, Ping; Choi, Sang-Il et al. (2013) Microscale polymer bottles corked with a phase-change material for temperature-controlled release. Angew Chem Int Ed Engl 52:10468-71
Moran, Christine H; Xia, Xiaohu; Xia, Younan (2013) Improving correlated SERS measurements with scanning electron microscopy: an assessment of the problem arising from the deposition of amorphous carbon. Phys Chem Chem Phys 15:5400-6
Wang, Yucai; Liu, Yongjian; Luehmann, Hannah et al. (2013) Radioluminescent gold nanocages with controlled radioactivity for real-time in vivo imaging. Nano Lett 13:581-5
Wang, Yucai; Black, Kvar C L; Luehmann, Hannah et al. (2013) Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment. ACS Nano 7:2068-77
Zeng, Jie; Goldfeld, David; Xia, Younan (2013) A plasmon-assisted optofluidic (PAOF) system for measuring the photothermal conversion efficiencies of gold nanostructures and controlling an electrical switch. Angew Chem Int Ed Engl 52:4169-73
Cho, Eun Chul; Zhang, Yu; Cai, Xin et al. (2013) Quantitative analysis of the fate of gold nanocages in vitro and in vivo after uptake by U87-MG tumor cells. Angew Chem Int Ed Engl 52:1152-5

Showing the most recent 10 out of 20 publications